Optimal control of therapies related to an oxytaxis glioblastoma model
Pith reviewed 2026-05-09 21:04 UTC · model grok-4.3
The pith
Existence of global optimal solutions is proven for controlling glioblastoma growth using chemotherapy and antiangiogenic therapies in an oxytaxis model.
A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.
Core claim
The paper establishes that for the optimal control problem associated with the oxytaxis glioblastoma model, a global optimal solution exists and first-order necessary optimality conditions can be obtained. The state system is a parabolic Keller-Segel-type model with random diffusion, oxytaxis, and reaction terms between tumor cells and oxygen. The cost functional penalizes both tumor growth and oxygen levels through the two therapeutic controls. A gradient-based numerical method is then used to approximate the optimal therapies in simulations.
What carries the argument
The optimal control problem for the Keller-Segel-type parabolic system with oxytaxis, where the two therapy intensities enter the reaction terms and optimality is characterized through the adjoint system derived from the state equations.
If this is right
- Global optimal therapy functions exist that achieve the infimum of the tumor-plus-oxygen cost.
- The first-order optimality conditions characterize the optimal controls via the adjoint state.
- The adjoint-based gradient together with the Adam optimizer produces computable approximations to those optimal therapies.
- Numerical experiments on the two-dimensional domain confirm that the computed therapies reduce the cost functional.
Where Pith is reading between the lines
- The same existence and optimality framework could be applied to three-dimensional domains or models that include additional cell types such as immune cells.
- If the model parameters are calibrated to patient imaging data, the numerical scheme could generate individualized therapy schedules.
- Similar control analysis might be carried out for other taxis-driven biological processes where two external interventions are available.
- Direct comparison of the predicted optimal dosing with clinical trial data would test whether the model's oxygen-taxis assumption holds in practice.
Load-bearing premise
The underlying parabolic system admits unique weak-strong solutions for the chosen reaction terms and boundary conditions.
What would settle it
A concrete parameter regime or boundary condition in which the PDE system loses uniqueness of weak-strong solutions, or a numerical simulation in which the adjoint-derived gradient fails to produce a control that reduces the cost functional.
Figures
read the original abstract
We propose and analyze an optimal control problem associated with a Keller-Segel type parabolic system with chemoattraction, modeling the glioblastoma growth in a bi-dimensional bounded domain, influenced by the presence of oxygen where the controls are two different (chemotherapy and antiangiogenic) therapies. The model considers the random diffusion of tumor cells and oxygen, the movement of cells towards the oxygen gradient (oxytaxis), and reaction terms describing the interaction between cells and oxygen. We establish a mathematical framework to analyze the existence and uniqueness of weak-strong solution of the model and subsequently we analyze an optimal control problem considering a cost functional that minimizes both the tumor growth and the oxygen concentration. We prove the existence of a global optimal solution and derive necessary first-order optimality conditions. Finally, we propose a methodology for approximating the optimal therapies. We use the gradient of the reduced cost functional through the adjoint scheme, and minimize the cost functional implementing the Adam gradient optimization method. Some numerical experiments are provided to demonstrate the effectiveness of the proposed scheme.
Editorial analysis
A structured set of objections, weighed in public.
Referee Report
Summary. The manuscript proposes an optimal control problem for a Keller-Segel-type parabolic system modeling glioblastoma growth in a bounded 2D domain, incorporating oxytaxis toward oxygen gradients. Controls represent chemotherapy and antiangiogenic therapies. The authors construct a framework proving existence and uniqueness of weak-strong solutions to the state system, establish existence of a global optimal solution pair, derive first-order necessary optimality conditions via an adjoint approach, and present a numerical approximation scheme that computes the gradient of the reduced cost functional (penalizing tumor density and oxygen levels) using the adjoint and minimizes it via the Adam optimizer, illustrated by numerical experiments.
Significance. If the well-posedness and optimality results hold, the work supplies a rigorous analytical and computational framework for therapy optimization in a biologically motivated PDE model with chemoattraction. A clear strength is the explicit construction of the adjoint-based gradient for the reduced functional combined with a modern optimizer (Adam) and supporting numerical experiments that demonstrate practical effectiveness. This combination of existence theory, necessary conditions, and reproducible numerics adds value for applied optimal control in cancer modeling, provided the core estimates are verified.
major comments (2)
- [Well-posedness section (likely §2 or §3)] The existence and uniqueness of weak-strong solutions to the state system (claimed in the abstract and developed in the well-posedness analysis) is load-bearing for both the optimal-control existence proof and the differentiability needed for the adjoint system. The manuscript must supply the explicit a-priori estimates (energy bounds or maximum-principle arguments) that control the quadratic oxytaxis term together with the chosen proliferation and consumption reaction terms to preclude finite-time blow-up on the bounded 2-D domain; any gap here renders the control-to-state map undefined.
- [Optimal control and adjoint section (likely §4)] In the derivation of the first-order optimality conditions (via the adjoint system), the paper assumes sufficient regularity of the control-to-state operator. The precise function spaces for the controls (e.g., L^∞ or L^2) and the states must be stated explicitly so that the linearized system and passage to the limit are justified; without this, the necessary conditions cannot be rigorously obtained.
minor comments (3)
- [Abstract] The abstract asserts proofs of existence, uniqueness, optimality conditions, and a numerical scheme; a short sentence indicating the main technical tools (e.g., Galerkin approximation plus compactness or fixed-point arguments) would orient readers without lengthening the abstract.
- [Numerical experiments] Numerical experiments section: the description of the Adam implementation should specify the learning rate schedule, iteration count, tolerance, and how the adjoint gradient is discretized to permit full reproducibility of the reported optimal therapies.
- [Figures] Figure captions for the simulation results should list the exact parameter values (diffusion coefficients, reaction rates, initial data) used, consistent with the model equations, to strengthen the reproducibility claim.
Simulated Author's Rebuttal
We thank the referee for the thorough review and insightful comments on our manuscript. We address each major comment below and plan to incorporate clarifications and additional details in the revised version to strengthen the rigor of our results.
read point-by-point responses
-
Referee: [Well-posedness section (likely §2 or §3)] The existence and uniqueness of weak-strong solutions to the state system (claimed in the abstract and developed in the well-posedness analysis) is load-bearing for both the optimal-control existence proof and the differentiability needed for the adjoint system. The manuscript must supply the explicit a-priori estimates (energy bounds or maximum-principle arguments) that control the quadratic oxytaxis term together with the chosen proliferation and consumption reaction terms to preclude finite-time blow-up on the bounded 2-D domain; any gap here renders the control-to-state map undefined.
Authors: We appreciate the referee's emphasis on the foundational role of the well-posedness results. In the manuscript, the existence and uniqueness of weak-strong solutions are established in Section 3 through a combination of Galerkin approximation, a priori estimates, and compactness arguments. The a priori bounds are obtained by testing the tumor cell equation with the density itself, utilizing the 2D Sobolev embedding to control the quadratic oxytaxis term (via |∇c| term bounded by L^2 norms), and leveraging the dissipative structure from the oxygen consumption and logistic proliferation terms to prevent blow-up. These estimates are global in time on the bounded domain. To make this more transparent, we will expand the well-posedness section with a dedicated lemma detailing these energy estimates and maximum principle arguments in the revision. revision: yes
-
Referee: [Optimal control and adjoint section (likely §4)] In the derivation of the first-order optimality conditions (via the adjoint system), the paper assumes sufficient regularity of the control-to-state operator. The precise function spaces for the controls (e.g., L^∞ or L^2) and the states must be stated explicitly so that the linearized system and passage to the limit are justified; without this, the necessary conditions cannot be rigorously obtained.
Authors: We agree that explicit specification of the function spaces is crucial for rigor. The controls are chosen in the admissible set U_ad subset L^∞(0,T; L^∞(Ω)) with pointwise bounds, ensuring boundedness and allowing for the application of the adjoint method. The state variables belong to appropriate spaces such as L^2(0,T; H^1(Ω)) ∩ L^∞(0,T; L^2(Ω)) for the tumor density and similar for oxygen. The differentiability of the control-to-state map is justified by the Lipschitz continuity from the well-posedness estimates. We will revise the optimal control section to explicitly state these spaces and provide a brief outline of the linearization and limit passage arguments. revision: yes
Circularity Check
No circularity: standard PDE well-posedness and adjoint derivation are independent of the target optimality result
full rationale
The paper first constructs a framework proving existence and uniqueness of weak-strong solutions to the Keller-Segel oxytaxis system (using a-priori estimates, compactness, and handling of the quadratic term on a bounded domain), then invokes this to establish existence of a global optimal control pair and to derive first-order necessary conditions via the adjoint system. These steps rely on external parabolic theory and standard optimal-control arguments rather than any self-definition, fitted-parameter renaming, or self-citation chain that reduces the claimed result to its own inputs by construction. No prediction or optimality condition is shown to be equivalent to a fitted quantity or prior ansatz from the same authors.
Axiom & Free-Parameter Ledger
Reference graph
Works this paper leans on
-
[1]
Anderson A.; Chaplin M.; Newman E.; Steele R. & Thompson A. (2000). Mathematical modelling of tumour invasion and metastasis.Computational and Mathematical Methods in Medicine.2(2), 129–154
work page 2000
- [2]
-
[3]
Bellomo N.; Bellouquid A.; Tao Y. & Winkler M. (2015). Toward a mathematical theory of Keller- Segel models of pattern formation in biological tissues.Math. Models Methods Appl. Sci.25(09), 1663–1763
work page 2015
-
[4]
Braz e Silva, P.; Guill´ en-Gonz´ alez, F.; Perusato, C.& Rodr´ ıguez-Bellido, M. A. (2023). Bilinear opti- mal control of the Keller–Segel logistic model in 2D-domains.Applied Mathematics & Optimization, 87, 55. A parabolic system with chemoattraction modeling the growth of glioma cells30
work page 2023
-
[5]
Chaplain M. (2000). Mathematical modelling of angiogenesis.Journal of Neuro-Oncology.50(1-2), 37–51
work page 2000
-
[6]
Chaplain M. Lolas G.(2006). Mathematical modelling of cancer invasion of tissue: dynamic hetero- geneity.Networks &; Heterogeneous Media1(13), 399–439
work page 2006
-
[7]
Colli, P.; Gomez, H.; Lorenzo, G.; Marinoschi, G.; Reali, A. & Rocca, E. (2021) Optimal control of cytotoxic and antiangiogenic therapies on prostate cancer growth.Mathematical Models and Methods in Applied Sciences.31(7), 1419–1468
work page 2021
- [8]
-
[9]
de Araujo A. & de Magalh˜ aes P. (2015). Existence of solutions and optimal control for a model of tissue invasion by solid tumours.J. Math. Anal. Appl.421(1), 842–877
work page 2015
-
[10]
Fernandez, L. (2022) Optimal control of a Fisher-KPP type model arising in chemotherapy for brain tumors.Pure and Applied Functional Analysis,7(5) 1637-1655
work page 2022
-
[11]
Fern´ andez-Romero, A.; Guill´ en-Gonz´ alez, F. & Su´ arez, A. (2022). A glioblastoma PDE–ODE model including chemotaxis and vasculature.ESAIM: Mathematical Modelling and Numerical Analysis, 56(2), 407–431
work page 2022
-
[12]
Feireisl, E. & Novotn´ y, A. (2009).Singular limits in thermodynamics of viscous fluids. Basel: Birkh¨ auser
work page 2009
-
[13]
G´ omez, H. (2017). Quantitative analysis of the proliferative-to-invasive transition of hypoxic glioma cells.Integrative Biology,9, 257–262
work page 2017
-
[14]
Hillen T. & Painter K. (2009). A user’s guide to PDE models for chemotaxis.J. Math. Biol.58(1-2), 183–217
work page 2009
- [15]
-
[16]
Keller, E. F., & Segel, L. A. (1971). Model for chemotaxis.Journal of theoretical biology,30(2), 225–234
work page 1971
-
[17]
(1969).Quelques m´ ethodes de r´ esolution des probl` emes aux limites non lin´ eaires
Lions, L., Jean J. (1969).Quelques m´ ethodes de r´ esolution des probl` emes aux limites non lin´ eaires. Paris: Dunod
work page 1969
-
[18]
L´ opez-Agredo, J. L.; Rueda-G´ omez, D. A.; Villamizar-Roa,´E. J. (2023). Theoretical and numerical analysis of a parabolic system with chemoattraction modeling the growth of glioma cells.Applied Numerical Mathematics,186, 143–163
work page 2023
-
[19]
L´ opez-Agredo, J. L.; Rueda-G´ omez, D. A.; Villamizar-Roa, ´E. J. (2023). Numerical analysis of a mathematical model describing the evolution of hypoxic glioma cells, Comput. Math. Appl. 131 (2023) 138–157
work page 2023
-
[20]
Menze B.; Bauer S. & Kalpathy J. (2015). The multimodal brain tumor image segmentation bench- mark (BRATS).IEEE Trans. Med. Imaging.34(10), 1993–2024
work page 2015
-
[21]
Ni˜ no-Celis, V; Rueda-G´ omez, D. A. & Villamizar-Roa,´E. J. (2021). Convergence and positivity of finite element methods for a haptotaxis model of tumoral invasion.Comput. Math. Appl.8920–33
work page 2021
-
[22]
Swanson, K. R. & Alvord, E. C. (2000). A quantitative model for differential motility of gliomas in grey and white matter.Cell Proliferation,33(5), 317–329. A parabolic system with chemoattraction modeling the growth of glioma cells31
work page 2000
-
[23]
Simon, J. (1987). Compact sets in the spaceL p(0, T;B).Annali di Matematica Pura ed Applicata, 146(4), 65–96
work page 1987
-
[24]
Winkler M. & Lankeit J. (2020). Facing low regularity in chemotaxis systems.Kahresber. Dtsh. Math.-Ver.122(1), 35–64
work page 2020
discussion (0)
Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.